Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4580852
Max Phase: Preclinical
Molecular Formula: C61H75ClN8O16S5
Molecular Weight: 1372.10
Molecule Type: Unknown
Associated Items:
ID: ALA4580852
Max Phase: Preclinical
Molecular Formula: C61H75ClN8O16S5
Molecular Weight: 1372.10
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C3/N(CCCS(=O)(=O)O)c4ccc(S(=O)(=O)O)cc4C3(C)C)=[N+](CCCS(=O)(=O)[O-])c3ccc(S(=O)(=O)O)cc31)c1nnc(C)n1-2
Standard InChI: InChI=1S/C61H75ClN8O16S5/c1-40-41(2)87-59-56(40)57(43-18-20-44(62)21-19-43)65-49(58-67-66-42(3)70(58)59)39-55(72)64-28-32-86-34-33-85-31-27-63-54(71)17-11-8-12-26-61(6)48-38-46(91(82,83)84)23-25-51(48)69(30-14-36-89(76,77)78)53(61)16-10-7-9-15-52-60(4,5)47-37-45(90(79,80)81)22-24-50(47)68(52)29-13-35-88(73,74)75/h7,9-10,15-16,18-25,37-38,49H,8,11-14,17,26-36,39H2,1-6H3,(H5-,63,64,71,72,73,74,75,76,77,78,79,80,81,82,83,84)/t49-,61?/m0/s1
Standard InChI Key: GMNBZAPLLBMPMH-YUYUPMSPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1372.10 | Molecular Weight (Monoisotopic): 1370.3593 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Richardson PL, Marin VL, Koeniger SL, Baranczak A, Wilsbacher JL, Kovar PJ, Bacon-Trusk PE, Cheng M, Hopkins TA, Haman ST, Vasudevan A.. (2019) Controlling cellular distribution of drugs with permeability modifying moieties., 10 (6): [PMID:31303996] [10.1039/C8MD00412A] |
Source(1):